MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Substance Abuse, Substance Use Disorder (SUD)_Opioid, Alcohol, Tobacco, Etc.
SPR Therapeutics
Organization & Developments: SPR
Parents
SPR Therapeutics
Children
*Medical device company that is commercializing pain treatments utilizing its peripheral nerve stimulation (PNS) products.
*Non-narcotic, reversible, safe, effective and affordable alternative to addictive opioid medications and invasive surgeries for acute and chronic pain management
*Peripheral nerve stimulation therapy platform designed to treat severe pain.
2011: Neurotech firm SPR Therapeutics gets $250K JumpStart investment (2011)
2011: Neurotechnology startup SPR Therapeutics expects to begin commercializing its first product, a pain relief device, by the end of 2011
2011: Year-old SPR (it stands for “stimulation for pain relief”) is one of the newest members of the Cleveland area’s growing cluster of neurotechnology firms (2011)
2016: SPR Therapeutics has developed a proprietary percutaneous peripheral nerve stimulation platform intended to address the critical unmet need for non-opioid, less-invasive, reversible and cost-effective treatments for acute pain
2016: SPR Therapeutics to Present at Military Health System Research Symposium
2017: SPR has received nearly $23 million to date in non-dilutive funding from the US Department of Defense, National Institutes of Health, and others
2017: SPR Therapeutics gets $25M for pain management wearable
2021: SPR Therapeutics scores $37M for pain relief tool and other digital health fundings
2026: Medtronic to acquire pain therapy developer SPR (MDT:NYSE) | Seeking Alpha
Industry: Medical Devices & Equipment Sub-Industry: Therapeutic Devices
Jumps
*Key People: SPR
Finance & Acquisitions: SPR